Targeting vascular inflammation through emerging methods and drug carriers is a research paper published in Advanced Drug Delivery Reviews (2022). On theSindex it has a DataRank of 0.593. It has been cited 51 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.593
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Heart Lung and Blood Institute
Grant: K99HL153696
National Heart Lung and Blood Institute
Grant: R01HL126874
National Heart Lung and Blood Institute
Grant: R01HL155106
National Heart Lung and Blood Institute
Grant: R01HL157189
NHLBI NIH HHS
Grant: R00 HL153696
NHLBI NIH HHS
Grant: R01 HL134839
National Institutes of Health
Grant: 1R01HL126874-01A1
Endothelial targeting of antioxidants
National Institutes of Health
Grant: 5R01HL157189-04
Dual drug delivery to lung/blood interface in respiratory infections.
National Institutes of Health
Grant: 1K99HL153696-01A1
FcRn-enabling strategies for improved thrombolytic therapy
National Institutes of Health
Grant: 1R01HL155106-01
Vascular Targeting of Nanocarriers for RNA
National Institutes of Health
FWCI
2.97
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals